Mark Newcomer | Chief Executive Officer |
Jeff Baker | Chief Financial Officer |
Gary Prestopino | Barrington |
Hello, and welcome to the PaySign First Quarter 2022 Earnings Conference Call.
As a reminder this conference is being recorded. This presentation may include comments that may be deemed to be forward-looking statements under federal securities laws and the company intends that such forward-looking statements be subject to the safe harbor created thereby. All statements other than statements of fact included in this release are forward-looking statements. Such forward-looking statements include among others that our unrestricted cash, anticipated revenues and profits will be sufficient to sustain operations for the next 12 months; that the expected total revenue, gross profit margins, operating expenses, depreciation and amortization, stock-based compensation, adjusted EBITDA, plasma revenues and pharma revenues for 2022 meet our expectations; that the company will continue to post year-over-year improvements; that the company's growth prospects in plasma, pharma and other prepaid business materialize; and that the company will continue to be affected by COVID-19-related to labor shortages.